rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

532872 SPARC Group (A)

Sun Pharma Advanced Research Company Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
408.80   4.10   1.01%
Volume 102,380
Prev close 404.70
Day's H/L (Rs.) 415.10 - 405.45
52wk H/L (Rs.) 598.00 - 158.90
Mkt Cap (Rs. Cr) 9,676.30
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

SPARC

Sun Pharma Advanced Research Company Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
409.65   3.80   0.94%
Volume 329,658
Prev close 405.85
Day's H/L (Rs.) 416.00 - 405.90
52wk H/L (Rs.) 598.00 - 158.75
Turnover (Rs. Lacs) 1,354.50
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Sun Pharma Advanced Research Company Ltd.  (See all 888 market voices)   

140 Characters
  Cancel
Deepak Manjrekar - 2 day(s) ago kay pagal ho kay buy...buy.. ye abhi buy karenge tho share market ko by karna padega
#Sun-Pharma-Advanced-Research-Company-Ltd
Reply   |   Share
Expert Calls - 3 day(s) ago buy buy...................................
#Sun-Pharma-Advanced-Research-Company-Ltd
Reply   |   Share
rahul - 3 days ago  SPARC net loss widens to Rs 9.40 crore in Q4
Reply   |  Share

Realtime news for Sun Pharma Advanced Research Company Ltd. (See all 154 news)

01 August 2015, 23:46
Corporate : SPARC Receives CRL from USFDA for Latanoprost NDA - 9 hour(s) ago
SPARC Rallies 4% On Licensing Xelpros To Sun Pharma - 10 Jun 2015
SPARC to raise Rs 250 crore through rights issue - 12 May 2015
USFDA denies approval for SPARC's anti-glaucoma eyedrop - 4 hour(s) ago
Retinitis Pigmentosa (Retinitis) Therapeutics Pipeline Review, H1 2015 - 24 Companies & 42 Drug Profiles - 4 day(s) ago

BSE Announcements from Sun Pharma Advanced Research Company Ltd. (See all)

Announces Q1 results & Limited Review Report for the Quarter ended June 30, 2015 - 11 hour(s) ago
SPARC Receives Complete Response Letter (CRL) from USFDA for Latanoprost NDA - 13 hour(s) ago

Company details for Sun Pharma Advanced Research Company Ltd.

Report Card

PE Ratios
-244.85
EPS (Rs.)
-1.67
Sales (Rs. Cr)
42.70
Face Value (Rs.)
1
Net Profit
Margin (%)
 
-25.37
Last Bonus
Last Dividend(%)
Return on
Average Equity
 
-39.59

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Sun Pharma Advanced Research Company Ltd. performance snapshot

If you had invested Rs.  in Sun Pharma Advanced Research Company Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Sun Pharma Advanced Research Company Ltd. with other stocks

Ranbaxy Laboratories Ltd.
814.10
Natco Pharma Ltd.
2,315.75
Show more companies
Ranbaxy Laboratories Ltd.
814.10
Natco Pharma Ltd.
2,315.75
Apollo Hospitals Enterprise Ltd.
1,326.05
Torrent Pharmaceuticals Ltd.
1,436.60
Ajanta Pharma Ltd.
1,552.15
Strides Arcolab Ltd.
1,257.90
Cipla Ltd.
710.10
Aurobindo Pharma Ltd.
723.50
Divi's Laboratories Ltd.
1,928.25
Ipca Laboratories Ltd.
694.10
Show less companies
Close
Add Sun Pharma Advanced Research Company Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Sun Pharma Advanced Research Company Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close